COVID-19 and liver transplantation: the jury is still out - Authors' reply.
作者信息
Webb Gwilym J, Marjot Thomas, Barnes Eleanor, Barritt Alfred S, Moon Andrew M
机构信息
Cambridge Liver Unit, Addenbrooke's Hospital, Cambridge, UK.
Oxford Liver Unit, Translational Gastroenterology Unit, Oxford University Hospitals NHS Foundation Trust, University of Oxford, UK.
出版信息
Lancet Gastroenterol Hepatol. 2021 Jan;6(1):11. doi: 10.1016/S2468-1253(20)30337-X. Epub 2020 Oct 30.
Abstract
摘要
相似文献
1
COVID-19 and liver transplantation: the jury is still out - Authors' reply.新型冠状病毒肺炎与肝移植：尚无定论——作者回复
Lancet Gastroenterol Hepatol. 2021 Jan;6(1):11. doi: 10.1016/S2468-1253(20)30337-X. Epub 2020 Oct 30.
2
COVID-19 and liver transplantation: the jury is still out.2019冠状病毒病与肝移植：尚无定论。
Lancet Gastroenterol Hepatol. 2021 Jan;6(1):10-11. doi: 10.1016/S2468-1253(20)30313-7. Epub 2020 Oct 30.
3
The authors reply.作者回复。
Kidney Int. 2020 Dec;98(6):1618-1619. doi: 10.1016/j.kint.2020.09.018. Epub 2020 Oct 13.
4
Gastrointestinal and liver involvement in patients with COVID-19 - Authors' reply.新型冠状病毒肺炎患者的胃肠道和肝脏受累——作者回复
Lancet Gastroenterol Hepatol. 2020 Sep;5(9):799-800. doi: 10.1016/S2468-1253(20)30240-5.
5
ChAdOx1 nCoV-19 vaccine for SARS-CoV-2 - Authors' reply.用于严重急性呼吸综合征冠状病毒2（SARS-CoV-2）的ChAdOx1新型冠状病毒疫苗——作者回复
Lancet. 2020 Nov 7;396(10261):1486-1487. doi: 10.1016/S0140-6736(20)32267-4.
6
Letter: SARS-CoV-2 induced gastrointestinal inflammation-authors' reply.信件：SARS-CoV-2 诱导的胃肠道炎症——作者的回复。
Aliment Pharmacol Ther. 2020 Dec;52(11-12):1750-1751. doi: 10.1111/apt.16117.
7
SARS-CoV-2 seroprevalence in Spain - Authors' reply.西班牙2019冠状病毒病血清流行率——作者回复
Lancet. 2020 Nov 7;396(10261):1484-1485. doi: 10.1016/S0140-6736(20)32266-2.
8
Probiotics and COVID-19 - Authors' reply.益生菌与2019冠状病毒病——作者回复
Lancet Gastroenterol Hepatol. 2020 Aug;5(8):722-723. doi: 10.1016/S2468-1253(20)30197-7.
9
SARS-CoV-2 infection in conjunctival tissue - Authors' reply.结膜组织中的严重急性呼吸综合征冠状病毒2感染——作者回复
Lancet Respir Med. 2020 Jul;8(7):e58. doi: 10.1016/S2213-2600(20)30273-3.
10
Effect of COVID-19 on maternal and neonatal services - Authors' reply.新型冠状病毒肺炎对孕产妇及新生儿服务的影响——作者回复
Lancet Glob Health. 2021 Feb;9(2):e116. doi: 10.1016/S2214-109X(20)30486-1. Epub 2020 Nov 20.
引用本文的文献
1
The Italian data on SARS-CoV-2 infection in transplanted patients support an organ specific immune response in liver recipients.意大利有关 SARS-CoV-2 感染移植患者的数据支持肝移植受者中存在器官特异性免疫反应。
Front Immunol. 2023 Jul 3;14:1203854. doi: 10.3389/fimmu.2023.1203854. eCollection 2023.
本文引用的文献
1
Outcomes following SARS-CoV-2 infection in patients with chronic liver disease: An international registry study.慢性肝病患者感染 SARS-CoV-2 后的结局：一项国际注册研究。
J Hepatol. 2021 Mar;74(3):567-577. doi: 10.1016/j.jhep.2020.09.024. Epub 2020 Oct 6.
2
Outcomes following SARS-CoV-2 infection in liver transplant recipients: an international registry study.肝移植受者感染 SARS-CoV-2 后的结局：一项国际注册研究。
Lancet Gastroenterol Hepatol. 2020 Nov;5(11):1008-1016. doi: 10.1016/S2468-1253(20)30271-5. Epub 2020 Aug 28.
3
SARS-CoV-2 infection and early mortality of waitlisted and solid organ transplant recipients in England: A national cohort study.英格兰等候名单和实体器官移植受者的 SARS-CoV-2 感染和早期死亡率：一项全国队列研究。
Am J Transplant. 2020 Nov;20(11):3008-3018. doi: 10.1111/ajt.16247. Epub 2020 Sep 16.
4
Epidemiological pattern, incidence, and outcomes of COVID-19 in liver transplant patients.肝移植患者 COVID-19 的流行病学模式、发病率和结局。
J Hepatol. 2021 Jan;74(1):148-155. doi: 10.1016/j.jhep.2020.07.040. Epub 2020 Aug 1.
5
Development and validation of QRISK3 risk prediction algorithms to estimate future risk of cardiovascular disease: prospective cohort study.用于估计心血管疾病未来风险的QRISK3风险预测算法的开发与验证：前瞻性队列研究
BMJ. 2017 May 23;357:j2099. doi: 10.1136/bmj.j2099.
6
Linkage of a national clinical liver transplant database with administrative hospital data: methods and validation.国家临床肝移植数据库与医院行政数据的链接：方法与验证。
Transplantation. 2014 Aug 15;98(3):341-7. doi: 10.1097/TP.0000000000000065.
Zotero 插件